Sanofi announces it will acquire Bioverativ
MLex Summary: Sanofi said on Monday it will acquire Waltham, Massachusetts-based Bioverativ for $11.6 billion. The transaction, which would give the French company a platform to expand in the rare blood...To view the full article, register now.
Already a subscriber? Click here to view full article